Why is Kopran Ltd ?
- The company has declared negative results for the last 5 consecutive quarters
- The company has declared negative results in Sep 24 after 4 consecutive negative quarters
- PAT(Q) At Rs -9.92 cr has Fallen at -234.4%
- ROCE(HY) Lowest at 5.38%
- OPERATING PROFIT TO INTEREST (Q) Lowest at -2.53 times
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
- Along with generating -36.92% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Kopran for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at Rs 37.14 cr
Highest at 3.66 times
At Rs -9.92 cr has Fallen at -234.4%
Lowest at 5.38%
Lowest at -2.53 times
Highest at 0.31 times
Lowest at Rs 117.91 cr
Lowest at Rs -5.28 cr.
Lowest at -4.48%
Lowest at Rs -11.66 cr.
Lowest at Rs -2.05
Here's what is working for Kopran
Cash and Cash Equivalents
Debtors Turnover Ratio
Here's what is not working for Kopran
Net Sales (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Interest
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
EPS (Rs)
Debt-Equity Ratio






